CJC 1295 (DAC) | 10 MG

CJC-1295 (with DAC) is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH), modified with a Drug Affinity Complex (DAC) that binds to albumin in the bloodstream, dramatically extending its half-life to approximately 6–8 days. This allows for sustained, continuous elevation of endogenous growth hormone (GH) and IGF-1 levels, providing a more steady-state profile compared to shorter-acting versions.

In research, CJC-1295 with DAC stimulates prolonged GH secretion (often 2–10-fold increases lasting 6+ days per dose) and IGF-1 elevation (1.5–3-fold for 9–11 days or longer with repeated dosing), while preserving some natural pulsatility in GH release patterns.

Potential human benefits (drawn from clinical pharmacokinetic studies showing sustained GH/IGF-1 increases, limited observations, and extensive anecdotal reports in longevity, fitness, anti-aging, and recovery communities):

• Sustained muscle growth and strength — elevated GH/IGF-1 supports ongoing protein synthesis, lean mass gains, muscle repair, and improved body composition over extended periods.
• Enhanced fat loss and metabolic support — promotes lipolysis, increased energy expenditure, and better fat metabolism for reduced body fat and leaner physique.
• Improved recovery and tissue repair — faster healing from workouts, injuries, or daily wear; reduced soreness; and greater overall resilience due to prolonged anabolic signaling.
• Better sleep, energy, and vitality — many users report deeper restorative sleep, sustained daytime energy, and a general sense of rejuvenation from consistent GH elevation.
• Anti-aging and wellness effects — potential for enhanced skin elasticity, bone density support, cognitive clarity hints, and slowed age-related decline through elevated IGF-1 and metabolic optimization.
• Convenience and steady benefits — longer half-life means less frequent dosing (often 1–2 times per week), providing a "baseline" GH boost for cumulative effects.

Human evidence primarily comes from studies demonstrating safe, dose-dependent GH/IGF-1 increases in healthy adults (with no serious adverse events at tested doses), preserved pulsatility, and cumulative IGF-1 elevation over weeks. Large-scale, long-term randomized trials on body composition or performance remain limited, with benefits often self-reported and synergistic with lifestyle factors.

Important Notice:

This product is intended for research use only.
Not for human or animal use of any kind.
Not a drug. Not approved for clinical or therapeutic use.

This product is intended for research use only.
Not for human or animal use of any kind.
Not a drug. Not approved for clinical or therapeutic use.